Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome

European Heart Journal: Acute Cardiovascular Care

Volumn 1, Issue 3, 2012, Pages 222-231

  Abu Assi, Emad ^a   Raposeiras Roubin, Sergio ^a   Lear, Pamela ^a   Cabanas Grandío, Pilar ^a   Girondo, Mar ^a   Rodríguez Cordero, Marta ^a   Pereira López, Eva ^a   Romaní, Santiago Gestal ^a   González Cambeiro, Cristina ^a   Alvarez Alvarez, Belén ^a   García Acuña, José María ^a   González Juanatey, José Ramón ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Acute coronary syndrome; haemorrhage; risk score

Indexed keywords

EID: 84990339274     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872612453924     Document Type: Article

References (23)

1. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005; 96: 1200-1206.
2. Eikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774-782.
3. Baber U, Kovacic J, Kini AS, et al. How serious a problem is bleeding in patients with acute coronary syndromes? Curr Cardiol Rep 2011; 13: 312-319.
4. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823.
5. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007; 28: 1936-1945.
6. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2009; 119: 1873-1882.
7. Mathews R, Peterson ED, Chen AY, et al. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry-GWTG. Am J Cardiol 2011; 107: 1136-1143.
8. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 2010; 55: 2556-2566.
9. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054.
10. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008; 29: 2909-2945.
11. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015.
12. Hanley JA and McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
13. DeLong ER, DeLong DM and Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
14. Lemeshow S and Hosmer D. A review of goodness of fit statistic for use in the development of logistic regression models. Am J Epidemiol 1982; 115: 92-106.
15. Abu-Assi E, Gracía-Acuña JM, Ferreira-González I, et al. Evaluating the performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction. Circulation 2010; 121: 2419-2426.
16. Kadakia M, Desai N, Alexander K, et al. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction. JACC Cardiovasc Interv 2010; 3: 1166-1177.
17. Laupacis A, Sekar N and Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 1997; 277: 488-494.
18. Altman DG and Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-473.
19. Yusuf S, Mehta SR, Chrolavicius S, et al.; Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 254: 1464-1476.
20. Stone GW, McLaurin BT, Cox DA, et al.; ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216.
21. Dauerman HL, Rao SV, Resnic FS, et al. Bleeding avoidance strategies: consensus and controversy. J Am Coll Cardiol 2011; 58: 1-10.
22. Kugelmass AD, Cohen DJ, Brown PP, et al. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol 2006; 97: 322-327.
23. Pinto DS, Stone GW, Shi C, et al. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol 2008; 52: 1758-1768.